LEADER 03675nam  22004935  450 
001 9910156296703321
005 20200629185833.0
010   $a981-10-2113-9
024 7 $a10.1007/978-981-10-2113-8
035   $a(CKB)3710000000985758
035   $a(DE-He213)978-981-10-2113-8
035   $a(MiAaPQ)EBC4773138
035   $a(PPN)19745402X
035   $a(EXLCZ)993710000000985758
100   $a20161221d2016      u|         0
101 0 $aeng
135   $aurnn|008mamaa
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPharmacokinetic and Pharmacodynamic Drug Interactions Associated with Antiretroviral Drugs /$fedited by Tony K. L. Kiang, Kyle John Wilby, Mary H. H. Ensom
205   $a1st ed. 2016.
210  1$aSingapore :$cSpringer Singapore :$cImprint: Adis,$d2016.
215   $a1 online resource (VII, 135 p. 40 illus., 25 illus. in color.) 
311   $a981-10-2112-0 
320   $aIncludes bibliographical references.
327   $a1. Introduction -- 2. HIV-Associated Comorbidities -- 3. Pharmacology and Pharmacokinetic Properties of Available Antiretrovirals -- 4. In Vitro Reaction Phenotyping and Drug Interaction Data -- 5. Clinical Drug-Drug Interaction Data: Effects of Co-administered Drugs on Pharmacokinetics of Antiretroviral Agents -- 6. Clinical Drug-Drug Interaction Data: Effects of Antiretroviral Agents on Co-administered Drugs -- 7. Pharmacodynamic Interactions Between Antiretrovirals and Other Agents -- 8. Conclusion and Clinical Decision Algorithm.
330   $aClinically-focussed, with easily accessible tables and chapter summaries suitable for clinicians and researchers, this comprehensive book provides a systematic, critical evaluation of the current literature. An updated clinical decision-making algorithm specifically tailored to the antiretroviral drugs is also provided. The identified interactions are interpreted in the context of known mechanisms derived from clinical, preclinical, and in vitro data. The clinical relevance of the interactions is systematically evaluated and gaps in literature discussed in the context of potential future experiments. In addition to the comprehensive summary of pharmacokinetic and pharmacodynamic drug interactions associated with WHO-recommended antiretroviral drugs on the market today (i.e. nucleotide reverse-transcriptase inhibitors, non-nucleoside reverse-transcriptase inhibitors, integrase inhibitors, and protease inhibitors), this book also provides detailed section summaries on the epidemiology of HIV infection, diagnosis and pharmacotherapy, basic pharmacology of the individual antiretrovirals, pertinent pre-clinical and in vitro molecular pharmacology, and in vitro drug interaction data available in the literature today. .
606   $aPharmacology
606   $aInfectious diseases
606   $aPharmacology/Toxicology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21007
606   $aInfectious Diseases$3https://scigraph.springernature.com/ontologies/product-market-codes/H33096
615  0$aPharmacology.
615  0$aInfectious diseases.
615 14$aPharmacology/Toxicology.
615 24$aInfectious Diseases.
676   $a615
702   $aKiang$b Tony K. L$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aWilby$b Kyle John$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aEnsom$b Mary H. H$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910156296703321
996   $aPharmacokinetic and Pharmacodynamic Drug Interactions Associated with Antiretroviral Drugs$92536176
997   $aUNINA